Sankey It
Loading...
Pfizer Inc. Q1 FY2026 income statement | Sankey It
Sankey It · PFE
Pfizer Inc. Q1 FY2026 income statement
USD · quarter ended 2026-03-29
Q2 FY2026
Q1 FY2026
Q4 FY2025
Q3 FY2025
Q2 FY2025
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Pfizer Inc. Q1 FY2026 income statement
Flow diagram with 8 nodes and 7 flows for Pfizer Inc. Q1 FY2026 income statement. Values: Revenue US$14.5B, Cost of Revenue US$4.7B, Gross Profit US$9.7B, Operating Expenses US$5.7B, Operating Income US$4B, Other Expense US$862M, Tax US$461M, Net Income US$2.7B.
Revenue
US$14.5B
Cost of Revenue
(US$4.7B)
33% of revenue
Gross Profit
US$9.7B
67% margin
Operating Expenses
(US$5.7B)
39% of revenue
Operating Income
US$4B
28% margin
Other Expense
(US$862M)
6% of revenue
Tax
(US$461M)
3% of revenue
Net Income
US$2.7B
19% margin
Net / profit
Tax / cost
Copy link
Share on X
Open full screen